Post date: 2020
Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery.
Georgia Tech researchers participate in entrepreneurial training to commercialize promising technology
Takayama lab develops a better tool for studying cancer, new geometrically-inverted organoids
An interdisciplinary mix of Georgia Tech researchers show proteins from deep, subsurface bacteria can change clathrate crystal structure
Post date: 2018
The biophysicist/pianist in Sam Brown’s lab wins Episode 3 quiz.
Petit Institute/BME researcher increasing the odds for neurosurgeons and their patients
Georgia Tech researcher developing new maps of global brain connectivity
Georgia Tech researcher working on a better way to deliver therapeutics for Alzheimer’s disease
Nano-electric technology may improve the drug development process.
Post date: 2019
Antibiotic-testing platform developed by a team that includes Peter Yunker gets a shot at commercialization.
Researchers have been awarded $6.25 million to use collective emergent behavior.
Researchers have captured and analyzed nearly all of the brain signals sent to the wings of hawk moths.
Georgia Tech and MIT researchers develop noninvasive treatment to improve memory and reduce amyloid plaques in mice
Post date: 2017
Annual gathering of regenerative medicine researchers looks to new opportunities
Ph.D. candidate from Jaydev Desai’s robotics lab earns top honor for best student paper
Post date: 2016
Integrated Cancer Research Center developing new weapons for war on cancer
Petit Institute researcher in first cohort to receive new award for early-career scientists
Post date: 2021
Colleagues and friends honor the remarkable life and work of Bridgette A. Barry, a renowned professor of biochemistry and biophysics in the School of Chemistry and Biochemistry, who also a longtime member of the Parker H. Petit Institute.
The procedure marries techniques from chemistry, biology, and data science and could help doctors design precision therapies for patients who aren’t responding to treatment.
Georgia Tech-Emory team receives multi-year funding in $50 million international effort targeting human immunology